| Rates of serious infection, including site‐specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti–tumor necrosis factor therapy … WG Dixon, K Watson, M Lunt, KL Hyrich, AJ Silman, DPM Symmons Arthritis & Rheumatism: Official Journal of the American College of …, 2006 | 940 | 2006 |
| Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR) WG Dixon, KL Hyrich, KD Watson, M Lunt, J Galloway, A Ustianowski, ... Annals of the rheumatic diseases 69 (3), 522-528, 2010 | 920 | 2010 |
| Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results … JB Galloway, KL Hyrich, LK Mercer, WG Dixon, B Fu, AP Ustianowski, ... Rheumatology 50 (1), 124-131, 2011 | 801 | 2011 |
| Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: results from the British Society … WG Dixon, KD Watson, M Lunt, KL Hyrich, AJ Silman, DPM Symmons Arthritis & Rheumatism: Official Journal of the American College of …, 2007 | 738 | 2007 |
| The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE) SM Langan, SAJ Schmidt, K Wing, V Ehrenstein, SG Nicholls, KB Filion, ... bmj 363, 2018 | 456 | 2018 |
| Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an … C Strehl, JWJ Bijlsma, M De Wit, M Boers, N Caeyers, M Cutolo, ... Annals of the rheumatic diseases 75 (6), 952-957, 2016 | 392 | 2016 |
| Serious infection following anti–tumor necrosis factor α therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies WG Dixon, DPM Symmons, M Lunt, KD Watson, KL Hyrich, AJ Silman Arthritis & Rheumatism: Official Journal of the American College of …, 2007 | 379 | 2007 |
| Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case–control analysis WG Dixon, M Abrahamowicz, ME Beauchamp, DW Ray, S Bernatsky, ... Annals of the rheumatic diseases 71 (7), 1128-1133, 2012 | 377 | 2012 |
| Genome-wide association analysis identifies novel loci for chronotype in 100,420 individuals from the UK Biobank JM Lane, I Vlasac, SG Anderson, SD Kyle, WG Dixon, DA Bechtold, S Gill, ... Nature communications 7 (1), 10889, 2016 | 322 | 2016 |
| Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative A Baillet, L Gossec, L Carmona, M de Wit, Y van Eijk-Hustings, ... Annals of the rheumatic diseases 75 (6), 965-973, 2016 | 305 | 2016 |
| Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor α therapy: results from the British Society for Rheumatology Biologics … MJ Harrison, WG Dixon, KD Watson, Y King, R Groves, KL Hyrich, ... Annals of the rheumatic diseases 68 (2), 209-215, 2009 | 280 | 2009 |
| Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology … WG Dixon, KL Hyrich, KD Watson, M Lunt, DPM Symmons, ... Annals of the rheumatic diseases 69 (6), 1086-1091, 2010 | 274 | 2010 |
| Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature E Nikiphorou, H Radner, K Chatzidionysiou, C Desthieux, C Zabalan, ... Arthritis research & therapy 18, 1-11, 2016 | 258 | 2016 |
| Predictors of distress in female breast cancer survivors: a systematic review A Syrowatka, A Motulsky, S Kurteva, JA Hanley, WG Dixon, ... Breast cancer research and treatment 165, 229-245, 2017 | 248 | 2017 |
| Influence of anti–tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: results from the British Society for … WG Dixon, KD Watson, M Lunt, LK Mercer, ... Arthritis care & research 62 (6), 755-763, 2010 | 245 | 2010 |
| Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register JB Galloway, KL Hyrich, LK Mercer, WG Dixon, AP Ustianowski, M Helbert, ... Annals of the rheumatic diseases 70 (10), 1810-1814, 2011 | 233 | 2011 |
| The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses WG Dixon, S Suissa, M Hudson Arthritis research & therapy 13, 1-14, 2011 | 221 | 2011 |
| A comparison of patient characteristics and outcomes in selected European and US rheumatoid arthritis registries JR Curtis, A Jain, J Askling, SL Bridges Jr, L Carmona, W Dixon, A Finckh, ... Seminars in arthritis and rheumatism 40 (1), 2-14. e1, 2010 | 217 | 2010 |
| Systemic glucocorticoid therapy and adrenal insufficiency in adults: a systematic review RM Joseph, AL Hunter, DW Ray, WG Dixon Seminars in arthritis and rheumatism 46 (1), 133-141, 2016 | 204 | 2016 |
| Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis LK Mercer, M Lunt, ALS Low, WG Dixon, KD Watson, DPM Symmons, ... Annals of the rheumatic diseases 74 (6), 1087-1093, 2015 | 202 | 2015 |
